Mission Wealth Management LP Takes Position in Colgate-Palmolive (NYSE:CL)

Mission Wealth Management LP bought a new position in Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,189 shares of the company’s stock, valued at approximately $254,000.

Other institutional investors have also recently bought and sold shares of the company. Dakota Wealth Management grew its position in Colgate-Palmolive by 73.3% during the third quarter. Dakota Wealth Management now owns 8,573 shares of the company’s stock valued at $610,000 after acquiring an additional 3,627 shares during the period. Raymond James & Associates grew its holdings in shares of Colgate-Palmolive by 1.2% during the 3rd quarter. Raymond James & Associates now owns 900,300 shares of the company’s stock worth $64,020,000 after purchasing an additional 10,446 shares during the period. Stratos Wealth Advisors LLC increased its position in Colgate-Palmolive by 6.1% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 9,201 shares of the company’s stock worth $654,000 after purchasing an additional 529 shares in the last quarter. J.W. Cole Advisors Inc. raised its holdings in Colgate-Palmolive by 5.0% in the third quarter. J.W. Cole Advisors Inc. now owns 13,853 shares of the company’s stock valued at $985,000 after buying an additional 663 shares during the period. Finally, Bailard Inc. lifted its position in Colgate-Palmolive by 25.2% during the third quarter. Bailard Inc. now owns 7,875 shares of the company’s stock valued at $560,000 after buying an additional 1,584 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 159,048 shares of company stock valued at $13,336,846. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of a number of research reports. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Morgan Stanley upped their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. UBS Group boosted their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Finally, The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a research note on Friday, March 1st. They set a “buy” rating and a $93.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Trading Down 0.0 %

Shares of NYSE CL opened at $92.88 on Friday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $93.25. The company has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a price-to-earnings-growth ratio of 3.39 and a beta of 0.40. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 13.21. The stock’s 50 day simple moving average is $88.22 and its 200 day simple moving average is $82.07.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.15%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.